臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"kuo s h"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 101-125 / 1327 (共54页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2022-04-26T07:50:29Z	Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer	Chen J.L.-Y.; Pan C.-K.; Lin Y.-L.; Tsai C.-Y.; Huang Y.-S.; WEN-CHI YANG; Hsu F.-M.; Kuo S.-H.; Shieh M.-J.
臺大學術典藏	2022-04-26T07:50:29Z	Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)	WEN-CHI YANG; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; Cheng J.C.-H.; Kuo S.-H.; Hsu F.-M.
臺大學術典藏	2022-04-25T07:36:16Z	Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation	Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; JIA-HAU LIU; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H.
臺大學術典藏	2022-04-25T07:36:11Z	Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; JIA-HAU LIU; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022-04-14T07:20:22Z	Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; FENG-MING TIEN; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022-03-25T02:05:46Z	Medulloblastoma in adults: Treatment outcome, relapse patterns, and prognostic factors	SHIH-FAN LAI; Wang C.-W.; Chen Y.-H.; Lan K.-H.; Cheng J.C.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-25T02:05:45Z	Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1�V2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy	SHIH-FAN LAI; Chen Y.-H.; Kuo W.-H.; Lien H.-C.; Wang M.-Y.; Lu Y.-S.; Lo C.; Kuo S.-H.; Cheng A.-L.; Huang C.-S.
臺大學術典藏	2022-03-25T02:05:45Z	Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion	Liang T.H.-K.; Kuo S.-H.; Wang C.-W.; Chen W.-Y.; Hsu C.-Y.; SHIH-FAN LAI; Tseng H.-M.; You S.-L.; Chen C.-M.; Tseng W.-Y.I.
臺大學術典藏	2022-03-25T02:05:44Z	The extent of edema and tumor synchronous invasion into the subventricular zone and corpus callosum classify outcomes and radiotherapy strategies of glioblastomas	Liang H.-K.T.; Chen W.-Y.; SHIH-FAN LAI; Su M.-Y.; You S.-L.; Chen L.-H.; Tseng H.-M.; Chen C.-M.; Kuo S.-H.; Tseng W.-Y.I.
臺大學術典藏	2022-03-25T02:05:43Z	The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation	SHIH-FAN LAI; Chen Y.-H.; Liang T.H.-K.; Hsu C.-Y.; Lien H.-C.; Lu Y.-S.; Huang C.-S.; Kuo S.-H.
臺大學術典藏	2022-03-25T02:05:42Z	Whether adjuvant radiotherapy is desired for postmastectomy patients with T1�VT2 tumors and 1�V3 positive axillary lymph nodes who received modern systemic therapy?	SHIH-FAN LAI; Huang C.-S.; Kuo S.-H.
臺大學術典藏	2022-03-15T05:39:28Z	High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country	Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; WEI-WU CHEN; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏	2022-03-10T02:31:38Z	Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer	PO-HAN LIN; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S.
臺大學術典藏	2022-03-10T02:31:37Z	Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer	Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S.
臺大學術典藏	2022-03-10T02:31:35Z	Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer	PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S.
臺大學術典藏	2022-03-10T02:31:34Z	Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy	PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S.
臺大學術典藏	2022-03-08T03:44:08Z	Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma	SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2022-03-08T03:44:08Z	Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2]	SHIH-HUNG YANG; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:07Z	Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma	SHIH-HUNG YANG; Lin L.-W.; Fang Y.-J.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:07Z	Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials	SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2022-03-08T03:44:06Z	Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-�eb is associated with a poor prognosis of pancreatic cancer	SHIH-HUNG YANG; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏	2022-03-08T03:44:05Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:04Z	Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-08T03:44:04Z	Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer	SHIH-HUNG YANG; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:03Z	Postoperative imaging and tumor marker surveillance in resected pancreatic cancer	Wu H.; Guo J.-C.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H.

显示项目 101-125 / 1327 (共54页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52587787 在线人数 : 800 教育部委托研究计画计画执行:国立台湾大学图书馆